{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:45:58Z","timestamp":1791049558753,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.beem.2006.09.004","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T07:24:59Z","timestamp":1165994699000},"page":"599-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Anti-M\u00fcllerian hormone receptor defect"],"prefix":"10.1016","volume":"20","author":[{"given":"Nathalie","family":"di Clemente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Belville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2006.09.004_bib1","series-title":"Pediatric Endocrinology","first-page":"1","article-title":"Sexual Differentiation","author":"Josso","year":"2003"},{"key":"10.1016\/j.beem.2006.09.004_bib2","first-page":"271","article-title":"Recherches sur la diff\u00e9renciation sexuelle de l'embryon de lapin. III. R\u00f4le des gonades foetales dans la diff\u00e9renciation sexuelle somatique","volume":"36","author":"Jost","year":"1947","journal-title":"Archives d'anatomie Microscopique et de Morphologie Exp\u00e9rimentale"},{"key":"10.1016\/j.beem.2006.09.004_bib3","first-page":"379","article-title":"Problems of fetal endocrinology: the gonadal and hypophyseal hormones","volume":"8","author":"Jost","year":"1953","journal-title":"Recent Progress in Hormone Research"},{"key":"10.1016\/j.beem.2006.09.004_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-X","article-title":"Isolation of the bovine and human genes for M\u00fcllerian inhibiting substance and expression of the human gene in animal cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.beem.2006.09.004_bib5","series-title":"Recent Progress in Hormone Research","first-page":"1","article-title":"Anti-M\u00fcllerian hormone, the Jost factor","author":"Josso","year":"1993"},{"key":"10.1016\/j.beem.2006.09.004_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2003.09.007","article-title":"AMH\/MIS: what we know already about the gene, the protein and its regulation","volume":"211","author":"Rey","year":"2003","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.beem.2006.09.004_bib7","first-page":"657","article-title":"M\u00fcllerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications","volume":"22","author":"Teixeira","year":"2001","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2006.09.004_bib8","doi-asserted-by":"crossref","first-page":"16421","DOI":"10.1073\/pnas.0508304102","article-title":"Mullerian Inhibiting Substance acts as a motor neuron survival factor in vitro","volume":"102","author":"Wang","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2006.09.004_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/jrf.0.0700473","article-title":"Origin of anti-M\u00fcllerian hormone in bovine freemartin fetuses","volume":"70","author":"Vigier","year":"1984","journal-title":"Journal of Reproduction and Fertility"},{"key":"10.1016\/j.beem.2006.09.004_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dmi014","article-title":"AMH and AMH receptor defects in persistent M\u00fcllerian duct syndrome","volume":"11","author":"Josso","year":"2005","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.beem.2006.09.004_bib11","series-title":"Cell and molecular biology of the testis","first-page":"1","article-title":"M\u00fcllerian inhibiting substance function during mammalian reproductive development","author":"Behringer","year":"1994"},{"key":"10.1016\/j.beem.2006.09.004_bib12","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1101\/gad.10.20.2577","article-title":"Genetic analysis of the M\u00fcllerian-inhibiting substance signal transduction pathway","volume":"10","author":"Mishina","year":"1996","journal-title":"Genes and Development"},{"key":"10.1016\/j.beem.2006.09.004_bib13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.beem.2006.09.004_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1242\/dev.120.1.189","article-title":"A novel member of the transmembrane serine\/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the M\u00fcllerian duct","volume":"120","author":"Baarends","year":"1994","journal-title":"Development"},{"key":"10.1016\/j.beem.2006.09.004_bib15","first-page":"1006","article-title":"Cloning, expression and alternative splicing of the receptor for anti- M\u00fcllerian hormone","volume":"8","author":"di Clemente","year":"1994","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.beem.2006.09.004_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1295-382","article-title":"Insensitivity to anti-M\u00fcllerian hormone due to a spontaneous mutation in the human anti-M\u00fcllerian hormone receptor","volume":"11","author":"Imbeaud","year":"1995","journal-title":"Nature Genetics"},{"key":"10.1016\/j.beem.2006.09.004_bib17","doi-asserted-by":"crossref","first-page":"30571","DOI":"10.1074\/jbc.271.48.30571","article-title":"Mutant isoforms of the anti-M\u00fcllerian hormone type II receptor\u00a0are not expressed at the cell membrane","volume":"271","author":"Faure","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2006.09.004_bib18","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1242\/dev.02383","article-title":"Mullerian inhibiting substance regulates its receptor\/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression","volume":"133","author":"Zhan","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.beem.2006.09.004_bib19","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1242\/dev.127.15.3349","article-title":"Molecular mechanisms of hormone-mediated M\u00fcllerian duct regression: involvement of beta-catenin","volume":"127","author":"Allard","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.beem.2006.09.004_bib20","doi-asserted-by":"crossref","first-page":"15601","DOI":"10.1073\/pnas.2636900100","article-title":"Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107","volume":"100","author":"Barbie","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2006.09.004_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1073\/pnas.0407772101","article-title":"Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance","volume":"102","author":"Renaud","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2006.09.004_bib22","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1073\/pnas.95.2.594","article-title":"Receptors for anti-mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation","volume":"95","author":"Racine","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2006.09.004_bib23","first-page":"53","article-title":"Autocrine and paracrine M\u00fcllerian inhibiting substance hormone signaling hormone in reproduction","volume":"55","author":"Ingraham","year":"2000","journal-title":"Recent Progress in Hormone Research"},{"key":"10.1016\/j.beem.2006.09.004_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1073\/pnas.221599298","article-title":"M\u00fcllerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo","volume":"99","author":"Segev","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2006.09.004_bib25","doi-asserted-by":"crossref","first-page":"28371","DOI":"10.1074\/jbc.M004554200","article-title":"M\u00fcllerian inhibiting substance inhibits breast cancer cell growth through an NF kappa B-mediated pathway","volume":"275","author":"Segev","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2006.09.004_bib26","doi-asserted-by":"crossref","first-page":"9348","DOI":"10.1073\/pnas.1633592100","article-title":"Regulation of gonadotropin gene expression by Mullerian inhibiting substance","volume":"100","author":"B\u00e9d\u00e9carrats","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2006.09.004_bib27","doi-asserted-by":"crossref","first-page":"29654","DOI":"10.1074\/jbc.273.45.29654","article-title":"Steroidogenic factor-1 regulates the transcription of the human anti- M\u00fcllerian hormone receptor","volume":"273","author":"Santa Barbara","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2006.09.004_bib28","doi-asserted-by":"crossref","first-page":"13831","DOI":"10.1073\/pnas.96.24.13831","article-title":"Transcriptional regulation of the rat M\u00fcllerian inhibiting substance type II receptor in rodent Leydig cells","volume":"96","author":"Teixeira","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.beem.2006.09.004_bib29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/27221","article-title":"Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a","volume":"395","author":"Parr","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.beem.2006.09.004_bib30","doi-asserted-by":"crossref","first-page":"26511","DOI":"10.1074\/jbc.M300804200","article-title":"Synergistic cooperation between the \u00e1-catenin signaling pathway and steroidogenic factor-1 in the activation of the M\u00fcllerian inhibiting substance type II","volume":"278","author":"Hossain","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2006.09.004_bib31","doi-asserted-by":"crossref","first-page":"27973","DOI":"10.1074\/jbc.M002704200","article-title":"Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-M\u00fcllerian hormone and its type II receptor","volume":"275","author":"Gou\u00e9dard","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2006.09.004_bib32","first-page":"946","article-title":"M\u00fcllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression","volume":"15","author":"Clarke","year":"2001","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.beem.2006.09.004_bib33","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1038\/sj.onc.1208686","article-title":"Role of type I receptors for anti-M\u00fcllerian hormone in the SMAT-1 Sertoli cell line","volume":"24","author":"Belville","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2006.09.004_bib34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ng1003","article-title":"Requirement of Bmpr1a for M\u00fcllerian duct regression during male sexual development","volume":"32","author":"Jamin","year":"2002","journal-title":"Nature Genetics"},{"key":"10.1016\/j.beem.2006.09.004_bib35","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1210\/endo.142.9.8393","article-title":"Ovarian granulosa cell tumors express a functional receptor for anti- M\u00fcllerian hormone in transgenic mice","volume":"142","author":"Dutertre","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2006.09.004_bib36","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1242\/dev.129.6.1487","article-title":"Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development","volume":"129","author":"Roberts","year":"2002","journal-title":"Development"},{"key":"10.1016\/j.beem.2006.09.004_bib37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1210\/me.2003-0358","article-title":"Mutations of the anti-M\u00fcllerian hormone gene in patients with persistent M\u00fcllerian duct syndrome: biosynthesis, secretion and processing of the abnormal proteins and analysis using a three-dimensional model","volume":"18","author":"Belville","year":"2004","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.beem.2006.09.004_bib38","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/hmg\/5.9.1269","article-title":"A 27 base-pair deletion of the anti-M\u00fcllerian type II receptor gene is the most common cause of the persistent M\u00fcllerian duct syndrome","volume":"5","author":"Imbeaud","year":"1996","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.beem.2006.09.004_bib39","first-page":"4390","article-title":"Autosomal recessive segregation of a truncating mutation of anti-M\u00fcllerian hormone type II receptor in a family affected by the persistent M\u00fcllerian duct syndrome contrasts with its dominant negative activity in vitro","volume":"86","author":"Messika-Zeitoun","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.09.004_bib40","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/bdra.10091","article-title":"Persistent M\u00fcllerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene","volume":"67","author":"Hoshiya","year":"2003","journal-title":"Birth Defects Research. Part A"},{"key":"10.1016\/j.beem.2006.09.004_bib41","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:37:19Z","timestamp":1761496639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X06000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1521690X06000753"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2006.09.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-M\u00fcllerian hormone receptor defect","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2006.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}